Cephaelis ipecacuanha spag. (Pot.-Angaben), Chinchona succirubra spag. (Pot.-Angaben), Aconitum napellus spag. (Pot.-Angaben), B - Resultats de la cerca

cefuroxim navamedic (cefuroxim villerton) stungulyfsstofn, lausn/dreifa 250 mg

navamedic asa - cefuroximum natríum - stungulyfsstofn, lausn/dreifa - 250 mg

meropenem sun stungulyfs-/innrennslisstofn, lausn 500 mg

sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg

meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 1 g

williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g

salazopyrin tafla 500 mg

pfizer aps - sulfasalazinum inn - tafla - 500 mg

salazopyrin en-tabs magasýruþolin tafla 500 mg

pfizer aps - sulfasalazinum inn - magasýruþolin tafla - 500 mg

solu-medrol stungulyfsstofn og leysir, lausn 40 mg

pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 40 mg

tobradex augndropar, dreifa

novartis healthcare a/s - dexamethasonum fosfat; tobramycinum inn - augndropar, dreifa

zinacef stungulyfs-/innrennslisstofn, lausn 1,5 g

sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1,5 g

zinacef stungulyfs-/innrennslisstofn, lausn 750 mg

sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg

solu-medrol stungulyfsstofn og leysir, lausn 125 mg

pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 125 mg